Skip to main content
TEVA $42.62 +0.12%
TEVA logo
TEVA · Teva Pharmaceutical Industries Ltd
Track TEVA — free
$42.62 +0.05 (+0.12%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$49.73B
Shares
1.17B
Volume · Nov 17 7.02M Avg daily vol (3M) 6.16M
All webcasts

Earnings call · FY2023 Q1

Teva Pharmaceutical Industries Ltd (TEVA) Q1 2023 Earnings Call

Concluded May 10, 2023
May 10, 2023
Period
FY2023 Q1
Runtime
—
Sources
2 artifacts
Revenue $3.66B +0% YoY
Diluted EPS -$0.20
Gross margin 43.2% -4.3 pp YoY
Net income -$220.00M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed May 10, 2023.

Metric Guided Actual
Revenues Maintained
Full year 2023
$14.8B – $15.4B $15.85B above
Non-GAAP diluted EPS Maintained
Full year 2023
$2.25 – $2.55 —

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

United States Segment$1.68B
Europe Segment$1.18B +2.4% YoY
International Markets$581.00M +18.1% YoY
Other Activities$219.00M -20.4% YoY
Full-screen source Call document